Researchers conducted a cohort study to try to characterize long-term treatment-related adverse effects and complications in ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib) as a monotherapy for the treatment ...

even during cancer treatment. Scientists also revealed that circular fragments of DNA called extrachromosomal DNA (ecDNA) is ...

The accelerated approval of Trodelvy for patients with metastatic urothelial cancer has been voluntarily withdrawn.

New report outlines long-term risks of prostate cancer treatment, highlighting potential impacts on quality of life and need ...

The risks of adverse effects and complications from treatment for prostate cancer are substantial and continue for years ...

Her oncologist, Ramy Sedhom, MD, suggested she take oxybutynin, an inexpensive drug for overactive bladder that has been ...

Patients with muscle-invasive bladder cancer who underwent whole pelvis radiation showed improved cancer-specific survival and overall survival.

Men who undergo prostate cancer treatment face a greatly increased risk of life-altering, long-term complications, a ...

All patients who were randomized to chemotherapy (docetaxel or vinflunine ... In the UK, approximately 10,500 people are diagnosed with bladder cancer each year, equating to 29 people every day (4).

Though they may seem like something from the future, these five cancer vaccines are available now. Here are details about who ...